Psoriasis Research Today is a free monthly online journal that collates and summarizes the latest research about Psoriasis, including details on treatment, prevention, medication, causes.

Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept.

Krell JM

Total Skin and Beauty Dermatology Center, Birmingham, Alabama 35205, USA.

This article reports on the combined use of alefacept and etanercept in 3 patients whose psoriasis failed to respond adequately to etanercept. All patients maintained improvement for at least 8 weeks after completing 12 weeks of alefacept. No adverse events or infections were reported, and CD4+ T-cell counts remained above normal limits.

Published 22 May 2006 in J Am Acad Dermatol, 54(6): 1099-101.
Full-text of this article is available online (may require subscription).

© 2004-2008 Psoriasis Research Today. All Rights Reserved.